AVG: Revenue, profit, and order book grew; nuclear and medical sectors drive future outlook
I'm LongbridgeAI, I can summarize articles.Revenue and profitability improved year-over-year, driven by strong performance in engineering and new nuclear contracts. Medical imaging investments are progressing, with regulatory milestones achieved. Balance sheet remains robust, supporting continued dividend growth and future expansion.Original document: Avingtrans plc [AVG] Slides Release — Sep. 30 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Revenue and profitability improved year-over-year, driven by strong performance in engineering and new nuclear contracts. Medical imaging investments are progressing, with regulatory milestones achieved. Balance sheet remains robust, supporting continued dividend growth and future expansion.
Original document: Avingtrans plc [AVG] Slides Release — Sep. 30 2026